Substrate promiscuity of inositol 1,4,5-trisphosphate kinase driven by structurally-modified ligands and active site plasticity.

Márquez-Moñino, María Ángeles; Ortega-García, Raquel; Whitfield, Hayley; Riley, Andrew M; Infantes, Lourdes; Garrett, Shane W; Shipton, Megan L; Brearley, Charles A et al. · Nat Commun · 2024

basic_science · Level V

Where this comes from

Abstract

D-myo-inositol 1,4,5-trisphosphate (InsP<sub>3</sub>) is a fundamental second messenger in cellular Ca<sup>2+</sup> mobilization. InsP<sub>3</sub> 3-kinase, a highly specific enzyme binding InsP<sub>3</sub> in just one mode, phosphorylates InsP<sub>3</sub> specifically at its secondary 3-hydroxyl group to generate a tetrakisphosphate. Using a chemical biology approach with both synthetised and established ligands, combining synthesis, crystallography, computational docking, HPLC and fluorescence polarization binding assays using fluorescently-tagged InsP<sub>3</sub>, we have surveyed the limits of InsP<sub>3</sub> 3-kinase ligand specificity and uncovered surprisingly unforeseen biosynthetic capacity. Structurally-modified ligands exploit active site plasticity generating a helix-tilt. These facilitated uncovering of unexpected substrates phosphorylated at a surrogate extended primary hydroxyl at the inositol pseudo 3-position, applicable even to carbohydrate-based substrates. Crystallization experiments designed to allow reactions to proceed in situ facilitated unequivocal characterization of the atypical tetrakisphosphate products. In summary, we define features of InsP<sub>3</sub> 3-kinase plasticity and substrate tolerance that may be more widely exploitable.

Medical subject headings